Evidence map›Paper›PMID 29524066›Full record

ReviewHeart failure reviews2018

Implantable devices for heart failure monitoring and therapy.

Maxwell Eyram Afari, Wajih Syed, Lana Tsao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Implantable devices for heart failure monitoring: the CardioMEMS™ system.European heart journal supplements : journal of the European Society of Cardiology · 2019
    Article
  11. Progress in heart failure treatment in Germany.Clinical research in cardiology : official journal of the German Cardiac Society · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maxwell Eyram AfariDivision of Cardiovascular Medicine, Steward St. Elizabeth's Medical Center, 736 Cambridge Street, Brighton, MA, 02135, USA. maxieafari@yahoo.co.uk.ORCID http://orcid.org/0000-0002-2881-3754
Wajih SyedDivision of Cardiovascular Medicine, Steward St. Elizabeth's Medical Center, 736 Cambridge Street, Brighton, MA, 02135, USA.
Lana TsaoDivision of Cardiovascular Medicine, Steward St. Elizabeth's Medical Center, 736 Cambridge Street, Brighton, MA, 02135, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF), the cardiovascular epidemic of the twenty-first century, is associated with significant comorbidities and high mortality. The prevalence of HF is estimated around 6.5 million people and is expected to increase to 8 million by the year 2030. The associated costs to care for these patients continue to increase. Despite the advancement of pharmacologic therapy with significant improvement in morbidity and mortality, the 5-year survival for heart failure still stands at 61%. The challenges faced by HF patients include difficulty with lifestyle modifications, nonadherence to complex medical regimens, financial limitations, lack of access to medical care, and unfavorable side effects. The sickest HF patients, who are ACC/AHA stage D, have advanced therapeutic options such as left ventricular assist devices and orthotopic heart transplant; however, the majority of patients are ACC/AHA stage C and/or not candidates for such advanced care. With constraints placed on hospitals by Medicare on HF readmissions as well as the multiple comorbidities imposed by this disease, intense interest is focused on the development of implantable devices as add-on therapy. This review discusses the innovative devices under varying stages of investigation or approved for monitoring and treatment of HF.

Indexed as

Defibrillators, ImplantableHeart-Assist DevicesHeart FailureEquipment DesignHumansMonitoring, PhysiologicTelemedicineHeart failureImplantable devicesMonitoringTherapy

Identifiers

PMID29524066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.